New nasal gel could soothe dry nose sufferers
NCT ID NCT07273318
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a medical device called Osmonar Nasal Gel against a saline solution in 60 adults with dry nose. Participants used the gel or saline twice daily for 14 days. Researchers measured symptom improvement, nasal crusting, and safety to see if the gel offers better relief.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Osmonar Nasal Gel (medical device)
- What this could lead to
- If it works, this could offer a new, safe option for people with dry nose to ease discomfort and crusting.
- What could go wrong
- This is a small, completed study with only 60 participants, so results may not apply to everyone. The gel may not work better than simple saline.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Sep 2021
- Finished
-
Dec 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥ 18 years old; 2. Patients affected by dry nose; 3. Willing to comply with study requirements, using the tested products for 14 consecutive days; 4. Readiness not to participate in another clinical study during this study; 5. Commitment to using contraceptive methods (for women of childbearing age only); 6. Negative pregnancy testing (beta human chorionic gonadotropin test in urine) at baseline (only for women in childbearing age); 7. Written informed consent by the participant. Exclusion Criteria: 1\. Known allergy or hypersensitivity to the components of the OSMONAR or of saline solution; 4. Lesions/infections in the nasal area; 5\. Use of preparations that may influence the study outcome within the last 2 weeks prior to baseline and during the study (e.g. antibiotics, corticosteroids etc.); 6\. History or presence of any other clinically significant known (self-reported) condition /disorder, which per investigator's judgement could interfere with the results of the study or the safety of the subject; 7\. Pregnancy, nursing or within first 3 months post-partum; 8\. History of or current abuse of drugs, alcohol or medication; 9\. Participation in another study during the last 30 days prior to baseline.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dry nose are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Otolaryngology - Presidio Ospedaliero di Lamezia Terme Giovanni Paolo II
Lamezia Terme, CZ, 88046, Italy